Clinical Trials · NCT04110145

Linaclotide Safety and Efficacy in 2 to 5-Year-Old Participants With Functional Constipation

Name: Linaclotide Safety and Efficacy in 2 to 5-Year-Old Participants With Functional Constipation
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 2Linaclotide

Phase: Phase 2
Recruitment status: Completed
Sponsor: Allergan
Enrollment: 35
Start date: Oct 2019
Locations: 18 sites, United States
Primary endpoint: Change From Baseline in 4-week Overall Spontaneous Bowel Movement (SBM) Frequency Rate (SBMs/Week) During the Study Intervention Period of Each Cohort

View Linaclotide compound reference